Doctors at Englewood Health in New Jersey are using the Ion endoluminal system from Intuitive Surgical to take tissue biopsies from the hard-to-reach outer third of the lung to identify early-stage lung cancer.WHY IT…
Continue Reading
A digital health collaboration is to evaluate the use of AI in chest x-rays in Glasgow, with the Scottish government, University of Glasgow, Qure.ai and NHS Greater Glasgow and Clyde jointly working to assess…
Continue Reading
BT Healthcare’s bid to leverage its corporate heft to help support the digital transformation of the NHS is moving to its next stage as it expands its partnerships in the areas of diagnostics and…
Continue Reading
By Shania Kennedy
December 05, 2023 – A deep learning model can accurately identify non-smokers at high risk for lung cancer using only routine chest X-rays, according to research presented at this year’s meeting of the…
Continue Reading
AI’s prowess predicts lung cancer risk in non-smokers through routine chest X-rays. The study unveils an advanced “CXR-Lung-Risk” model, identifying 28% of participants at significantly higher risk. Dr. Lu emphasizes its pivotal role amid…
Continue Reading
What You Should Know:
– The American Cancer Society (ACS) and Color Health have announced a new program to provide free lung cancer screening access to eligible individuals.
– The program will make it easy for…
Continue Reading
Lunit deploys AI CXR solution to military units in South Korea, PhillippinesLunit, a provider of AI diagnostic support solutions, continues to supply its AI-powered chest x-ray screening solution to military health institutions across Asia-Pacific.
Recently, the…
Sixty four trusts are to get a share of a £21m AI Diagnostic Fund that has been allocated to roll out artificial intelligence (AI) tools to help speed up the diagnosis and treatment of…
Continue Reading
The LungIMPACT trial – a collaborative study between UK academia, NHS hospitals and Qure.ai is now gathering real-world evidence of AI-assisted diagnosis of lung cancer.Using Qure.ai’s gXR solution, the LungIMPACT trial is triaging chest…
Continue Reading
A groundbreaking study reveals the effectiveness of liquid biopsy tests in guiding personalized treatment for non-small cell lung cancer (NSCLC) patients. Unlike conventional methods, these tests focus on circulating tumor DNA (ctDNA) levels, providing…
Continue Reading
